SOLACI-SOCIME 2022 Is Over: We Will Meet Again at SOLACI-SBHCI 2023!

After 3 days of intense scientific activities, the SOLACI-SOCIME 2022 Congress has come to an end. We enjoyed 3 days of academic excellence, with 4 rooms for simultaneous activities, 1 digital plaza, and 3 rooms for our satellite symposiums: ProEducar, Pediatrics, and Technicians and Nurses. 

During the Congress, the most relevant current topics in interventional cardiology were covered, and challenging live cases, edited cases, and international joint sessions were presented. Specialists from all corners of Latin America delivered countless lectures.

In that sense, over 1300 professionals witnessed this great event, while more than 500 people were able to enjoy the Main Arena sessions virtually. 

During the closing ceremony, Dr. Guering Eid Lidt, President of the SOLACI-SOCIME 2022 Scientific Committee, valued the hard teamwork of members of both associations to offer “a Congress at the level of what SOLACI and SOCIME demand, reaching a high academic level in this return to on-site events.” 

Furthermore, Dr. Aníbal Damonte, SOLACI President, highlighted the high attendance to the event—both in person and virtually—and congratulated the Organizing and Scientific Committee for the “excellent organization and the high level of the scientific program.” He also added: SOLACI and SOCIME took on a real challenge four months ago, but we understood that, despite the uncertainty caused by the pandemic, there was a need to return to on-site events. And we were not wrong.”

Dr. Andrés García Rincón, SOCIME President, thanked the medical industry for its collaboration and praised the joint work of both associations. Finally, he addressed the attendees, noting that “this Congress is from you and for you.”

At the end, Dr. Damonte left an open invitation to the SOLACI-SBHCI 2023 Congress, to be held on August 2-4, 2023, at the Windsor Hotel in Barra de Tijuca, Rio de Janeiro, Brazil, and called to continue working to expand the development of interventional cardiology in the region.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...